TREM1 and systemic inflammatory response syndrome: Considering that this receptor is capable of amplifying the inflammatory response and some new research data on this receptor participation in the development of noninfectious SIRS a study investigating the potential use of soluble TREM-1 as a marker of postoperative SIRS intensity and its complications after direct on-pump myocardial revascularization can be of interest [8, 9].